凝血指标对妊娠急性脂肪肝患者预后的评估价值
该回顾性分析纳入郑州大学第一附属医院ICU 2010年1月至2021年5月的64例妊娠急性脂肪肝(AFLP)患者,按28天预后分为死亡组(14例,病死率21.9%)与存活组(50例,存活率78.1%)。死亡组男性胎儿比例和死胎比例高于存活组,白细胞计数、丙氨酸转氨酶、血清肌酐、凝血酶原时间延长、国际标准化比值升高及高氨血症均显著高于存活组(均P<0.05)。Logistic回归显示PT>14 s和INR>1.5是影响预后的危险因素。ROC曲线分析显示入住ICU时及治疗24、48、72小时的PT和INR均可评估预后,治疗72小时后预测价值最高。
要点
- AFLP患者28天病死率21.9%(14/64),死亡组男性胎儿比例和死胎比例高于存活组。
- 死亡组白细胞计数、丙氨酸转氨酶、血清肌酐、PT延长、INR升高及高氨血症均显著高于存活组(均P<0.05)。
- Logistic回归显示PT>14 s是影响AFLP预后的危险因素(OR=1.215,95%CI 1.076-1.371,P<0.01)。
- 治疗72小时后PT的AUC为0.957(95%CI 0.904-1.000),敏感性93.5%,特异性90.9%。
- 治疗72小时后INR的AUC为0.952(95%CI 0.896-1.000),敏感性91.8%,特异性90.9%。
适用人群与场景
- 2010年1月至2021年5月郑州大学第一附属医院ICU收治的妊娠急性脂肪肝(AFLP)患者64例,发病孕周(34.5±6.8)周。
- 按28天预后分为死亡组14例和存活组50例。
诊断标准与关键阈值
- PT>14 s为影响AFLP患者预后的危险因素(OR=1.215,95%CI 1.076-1.371,P<0.01)。
- INR>1.5为影响AFLP患者预后的危险因素(OR=0.719,95%CI 0.624-0.829,P<0.01)。
处置流程与药物剂量
- 一旦发现AFLP应立即终止妊娠。
红旗征与不能漏的情况
- 死亡组男性胎儿比例和死胎比例高于存活组。
- 死亡组白细胞计数、丙氨酸转氨酶、血清肌酐、PT延长、INR升高及高氨血症均显著高于存活组(均P<0.05)。
研究设计与关键结果
- 回顾性分析纳入64例AFLP患者,死亡14例(病死率21.9%),存活50例(存活率78.1%)。
- 两组年龄、发病至就诊时间、就诊至终止妊娠时间、APACHE II评分、ICU住院时间及总住院费用差异均无统计学意义。
- 死亡组男性胎儿比例和死胎比例高于存活组。
- 死亡组白细胞计数、丙氨酸转氨酶、血清肌酐、PT延长、INR升高及高氨血症均显著高于存活组(均P<0.05)。
- Logistic回归显示PT>14 s(OR=1.215,95%CI 1.076-1.371,P<0.01)和INR>1.5(OR=0.719,95%CI 0.624-0.829,P<0.01)是影响AFLP患者预后的危险因素。
- 入住ICU时及治疗24、48、72小时的PT均可评估预后,AUC(95%CI)分别为0.772(0.599-0.945)、0.763(0.608-0.918)、0.879(0.795-0.963)、0.957(0.904-1.000),均P<0.05。
- 入住ICU时及治疗24、48、72小时的INR均可评估预后,AUC(95%CI)分别为0.808(0.650-0.966)、0.730(0.564-0.896)、0.854(0.761-0.947)、0.952(0.896-1.000),均P<0.05。
- 治疗72小时后PT和INR的AUC最高,敏感性分别为93.5%和91.8%,特异性均为90.9%。
证据类型、等级与局限
- 证据类型:回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- AFLP常发生于妊娠中晚期,初期症状以消化道症状为主。
- 作者认为:一旦发现AFLP应立即终止妊娠。
- PT和INR是评估AFLP患者疗效和预后的良好指标,治疗72小时后的PT和INR是最佳预后指标。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the relevant clinical test indicators that affect the prognosis of patients with acute fatty liver of pregnancy (AFLP), and to provide a basis for early diagnosis and correct selection of treatment methods.
METHODS: A retrospective analysis was conducted. Clinical data of AFLP patients in the intensive care unit (ICU) of the First Affiliated Hospital of Zhengzhou University from January 2010 to May 2021 were collected. According to the 28-day prognosis, the patients were divided into death group and survival group. The clinical data, laboratory examination indicators, and prognosis of the two groups were compared, and further binary Logistic regression analysis was used to analyze the risk factors affecting the prognosis of patients. At the same time, the values of related indicators at each time point (24, 48, 72 hours) after the start of treatment were recorded. The receiver operator characteristic curve (ROC curve) of prothrombin time (PT) and international normalized ratio (INR) for evaluating the prognosis of patients at each time point was drawn, and the area under the ROC curve (AUC) was calculated to evaluate the predictive value of relevant indicators at each time point for the prognosis of AFLP patients.
RESULTS: A total of 64 AFLP patients were selected. The patients developed the AFLP during pregnancy (34.5±6.8) weeks, with 14 deaths (mortality of 21.9%) and 50 survivors (survival rate of 78.1%). There was no statistically significant difference in general clinical data between the two groups of patients, including age, time from onset to visit, time from visit to cessation of pregnancy, acute physiology and chronic health evaluations II (APACHE II), hospitalization time in ICU, and total hospitalization cost. However, the proportion of male fetuses and stillbirths in the death group was higher than that in the survival group. The laboratory examination indicators including the white blood cell count (WBC), alanine transaminase (ALT), serum creatinine (SCr), PT extension, INR elevation, and hyperammonia in the death group were significantly higher than those in the survival group (all P < 0.05). Through Logistic regression analysis of the above indicators showed that PT > 14 s and INR > 1.5 were risk factors affecting the prognosis of AFLP patients [PT > 14 s: odds ratio (OR) = 1.215, 95% confidence interval (95%CI) was 1.076-1.371, INR > 1.5: OR = 0.719, 95%CI was 0.624-0.829, both P < 0.01]. ROC curve analysis showed that both PT and INR at ICU admission and 24, 48, and 72 hours of treatment can evaluate the prognosis of AFLP patients [AUC and 95%CI of PT were 0.772 (0.599-0.945), 0.763 (0.608-0.918), 0.879 (0.795-0.963), and 0.957 (0.904-1.000), respectively; AUC and 95%CI of INR were 0.808 (0.650-0.966), 0.730 (0.564-0.896), 0.854 (0.761-0.947), and 0.952 (0.896-1.000), respectively; all P < 0.05], the AUC of PT and INR after 72 hours of treatment was the highest, with higher sensitivity (93.5%, 91.8%) and specificity (90.9%, 90.9%).
CONCLUSIONS: AFLP often occurs in the middle and late stages of pregnancy, and the initial symptoms are mainly gastrointestinal symptoms. Once discovered, pregnancy should be terminated immediately. PT and INR are good indicators for evaluating AFLP patient efficacy and prognosis, and PT and INR are the best prognostic indicators after 72 hours of treatment.
参考来源
- Yang H, Liang M, Li P, et al. [Prognostic evaluation of coagulation indicators for patients with acute fatty liver of pregnancy]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 37366127. doi:10.3760/cma.j.cn121430-20230420-00299
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。